Comparison between clinical disabilities and electrophysiological values in Charcot-Marie-Tooth 1A patients with PMP22 duplication
- PMID: 22787498
- PMCID: PMC3391619
- DOI: 10.3988/jcn.2012.8.2.139
Comparison between clinical disabilities and electrophysiological values in Charcot-Marie-Tooth 1A patients with PMP22 duplication
Abstract
Background and purpose: Charcot-Marie-Tooth disease (CMT) type 1A (CMT1A) is the demyelinating form of CMT that is significantly associated with PMP22 duplication. Some studies have found that the disease-related disabilities of these patients are correlated with their compound muscle action potentials (CMAPs), while others have suggested that they are related to the nerve conduction velocities. In the present study, we investigated the correlations between the disease-related disabilities and the electrophysiological values in a large cohort of Korean CMT1A patients.
Methods: We analyzed 167 CMT1A patients of Korean origin with PMP22 duplication using clinical and electrophysiological assessments, including the CMT neuropathy score and the functional disability scale.
Results: Clinical motor disabilities were significantly correlated with the CMAPs but not the motor nerve conduction velocities (MNCVs). Moreover, the observed sensory impairments matched the corresponding reductions in the sensory nerve action potentials (SNAPs) but not with slowing of the sensory nerve conduction velocities (SNCVs). In addition, CMAPs were strongly correlated with the disease duration but not with the age at onset. The terminal latency index did not differ between CMT1A patients and healthy controls.
Conclusions: In CMT1A patients, disease-related disabilities such as muscle wasting and sensory impairment were strongly correlated with CMAPs and SNAPs but not with the MNCVs or SNCVs. Therefore, we suggest that the clinical disabilities of CMT patients are determined by the extent of axonal dysfunction.
Keywords: CMT1A; charcot-marie-tooth disease; compound muscle action potential; duplication; nerve conduction velocity; sensory nerve action potential.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures

Similar articles
-
Nerve conduction velocity in CMT1A: what else can we tell?Eur J Neurol. 2016 Oct;23(10):1566-71. doi: 10.1111/ene.13079. Epub 2016 Jul 14. Eur J Neurol. 2016. PMID: 27412484 Free PMC article. Clinical Trial.
-
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.Brain. 2000 Jul;123 ( Pt 7):1516-27. doi: 10.1093/brain/123.7.1516. Brain. 2000. PMID: 10869062 Clinical Trial.
-
Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.Brain. 2003 Jan;126(Pt 1):134-51. doi: 10.1093/brain/awg012. Brain. 2003. PMID: 12477701 Review.
-
Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.J Peripher Nerv Syst. 2008 Dec;13(4):299-304. doi: 10.1111/j.1529-8027.2008.00196.x. J Peripher Nerv Syst. 2008. PMID: 19192070
-
Charcot-Marie-Tooth disease and related inherited neuropathies.Medicine (Baltimore). 1996 Sep;75(5):233-50. doi: 10.1097/00005792-199609000-00001. Medicine (Baltimore). 1996. PMID: 8862346 Review.
Cited by
-
Segregation analysis in families with Charcot-Marie-Tooth disease allows reclassification of putative disease causing mutations.BMC Med Genet. 2014 Jan 21;15:12. doi: 10.1186/1471-2350-15-12. BMC Med Genet. 2014. PMID: 24444136 Free PMC article.
-
One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families.Front Neurol. 2022 Jan 28;12:736704. doi: 10.3389/fneur.2021.736704. eCollection 2021. Front Neurol. 2022. PMID: 35153971 Free PMC article.
-
New evidence for secondary axonal degeneration in demyelinating neuropathies.Neurosci Lett. 2021 Jan 23;744:135595. doi: 10.1016/j.neulet.2020.135595. Epub 2020 Dec 24. Neurosci Lett. 2021. PMID: 33359733 Free PMC article. Review.
-
Studying cerebellar dysfunction in neuropathy-related tremor.Clin Neurophysiol. 2015 Sep;126(9):1645-6. doi: 10.1016/j.clinph.2015.01.003. Epub 2015 Jan 16. Clin Neurophysiol. 2015. PMID: 25691155 Free PMC article. No abstract available.
-
Paternal gender specificity and mild phenotypes in Charcot-Marie-Tooth type 1A patients with de novo 17p12 rearrangements.Mol Genet Genomic Med. 2020 Sep;8(9):e1380. doi: 10.1002/mgg3.1380. Epub 2020 Jul 9. Mol Genet Genomic Med. 2020. PMID: 32648354 Free PMC article.
References
-
- Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66:219–232. - PubMed
-
- Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, et al. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat. 2004;24:185–186. - PubMed
-
- Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med. 1993;329:96–101. - PubMed
-
- Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology. 2008;70:378–383. - PubMed
LinkOut - more resources
Full Text Sources